Race and sex differences in the initiation of diabetes drugs by privately insured US adults

Endocrine. 2021 Aug;73(2):480-484. doi: 10.1007/s12020-021-02710-4. Epub 2021 Apr 8.

Rozalina G McCoy^{1

2}, Holly K Van Houten^{3

4}, Shannon M Dunlay^{3

5}, Xiaoxi Yao^{3

5}, Timothy Dempsey⁶, Peter A Noseworthy^{3

5}, Lindsey R Sangaralingham³, Andrew H Limper^{3

6}, Nilay D Shah^{3

4}

¹ Department of Medicine, Division of Community Internal Medicine, Mayo Clinic, Rochester, MN, USA. mccoy.rozalina@mayo.edu.
² Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, MN, USA. mccoy.rozalina@mayo.edu.
³ Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, MN, USA.
⁴ OptumLabs, Cambridge, MA, USA.
⁵ Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
⁶ Department of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.

No abstract available

Publication types